REAR END COLLISION SHOCK ABSORBING UNIT, RECLINING DEVICE, AND FRAMED STRUCTURE OF VEHICLE SEAT
    1.
    发明申请
    REAR END COLLISION SHOCK ABSORBING UNIT, RECLINING DEVICE, AND FRAMED STRUCTURE OF VEHICLE SEAT 审中-公开
    后端碰撞冲击吸收装置,拆卸装置和车辆框架结构

    公开(公告)号:US20080315635A1

    公开(公告)日:2008-12-25

    申请号:US12143828

    申请日:2008-06-23

    IPC分类号: B60R21/00

    CPC分类号: B60N2/42709 B60N2/42745

    摘要: A rear end collision shock absorbing unit wherein there are provided one-side member rotating in synchronization with either one side of the seat back side and the seat cushion side between members that turn mutually to enable tilting, and the other-side member rotating in synchronization with the other side, and a convex part is provided on the one-side member, a concave part or a through hole in which the convex part fits is provided in the other-side member, and when a rear end collision shock is applied, the convex part and the concave part or through hole are turned relatively and deformed in a fitted state, whereby rear end collision shock energy is absorbed.

    摘要翻译: 一种后端碰撞冲击吸收单元,其中设置有与座椅靠背侧的任一侧同步的单侧构件和彼此相对转动以能够倾斜的构件之间的座垫侧同步旋转,另一侧构件同步旋转 另一方面,在一侧构件上设置有凸部,在另一侧构件中设置凸部嵌合的凹部或贯通孔,在施加后端碰撞冲击时, 凸部和凹部或通孔在嵌合状态下相对转动并变形,从而吸收后端碰撞冲击能。

    Vehicle seat
    2.
    发明授权
    Vehicle seat 失效
    车座

    公开(公告)号:US07731281B2

    公开(公告)日:2010-06-08

    申请号:US11804894

    申请日:2007-05-21

    IPC分类号: B60R21/00

    摘要: An impact absorbing plate 31 is disposed between a front part 31z of the impact absorbing plate 31 and a vehicle body 11 so that a rupture generating part 44 ruptured by impact is extended in the front and rear direction of the vehicle, and the impact absorbing plate 31 is fixed to a front part 13a and a rear part 13b of the front seat bracket 13 provided in the vehicle body by rivets 33 and 33. A portion of front part 31z of the impact absorbing plate 31 is cut to form a cutoff part 45, and a front end 17a of a rail 17 provided in a seat section is attached to a convex part 35, which is molded so as to expand upward an inner side of the cutoff part 45, by a rivet 34.

    摘要翻译: 冲击吸收板31设置在冲击吸收板31的前部31z和车身11之间,使得通过冲击破裂的破裂产生部44在车辆的前后方向上延伸,并且冲击吸收板 31通过铆钉33和33固定在设置在车身中的前排座椅支架13的前部13a和后部13b上。冲击吸收板31的前部31z的一部分被切割以形成切断部45 并且设置在座椅部分中的轨道17的前端17a被安装在凸起部分35上,凸部35通过铆钉34被模制成向上延伸到切割部分45的内侧。

    Vehicle seat
    3.
    发明申请
    Vehicle seat 失效
    车座

    公开(公告)号:US20070273186A1

    公开(公告)日:2007-11-29

    申请号:US11804894

    申请日:2007-05-21

    IPC分类号: B60R21/00

    摘要: An impact absorbing plate 31 is disposed between a front part 31z of the impact absorbing plate 31 and a vehicle body 11 so that a rupture generating part 44 ruptured by impact is extended in the front and rear direction of the vehicle, and the impact absorbing plate 31 is fixed to a front part 13a and a rear part 13b of the front seat bracket 13 provided in the vehicle body by rivets 33 and 33. A portion of front part 31z of the impact absorbing plate 31 is cut to form a cutoff part 45, and a front end 17a of a rail 17 provided in a seat section is attached to a convex part 35, which is molded so as to expand upward an inner side of the cutoff part 45, by a rivet 34.

    摘要翻译: 冲击吸收板31设置在冲击吸收板31的前部31z和车身11之间,使得通过冲击而破裂的破裂产生部44在车辆的前后方向上延伸,并且冲击吸收 板31通过铆钉33和33固定在设置在车体中的前座椅支架13的前部13a和后部13b上。冲击吸收板31的前部31z的一部分被切割以形成 切割部分45和设置在座部分中的轨道17的前端17a被安装在凸起部分35上,凸部35通过铆钉34模制成向上延伸到切割部分45的内侧。

    N-substituted 3,4-dihydropyrimidine compounds as agents for treating
disorders of cardiovascular system
    4.
    发明授权
    N-substituted 3,4-dihydropyrimidine compounds as agents for treating disorders of cardiovascular system 失效
    N-取代的3,4-二氢嘧啶化合物作为治疗心血管系统疾病的药剂

    公开(公告)号:US4920124A

    公开(公告)日:1990-04-24

    申请号:US157777

    申请日:1988-02-19

    CPC分类号: C07D239/20

    摘要: N-substituted 3,4-dihydropyrimidine compounds of the formula: ##STR1## wherein R is straight, branched, cyclic or cyclo-straight alkyl having from one to four carbon atoms; and X.sup.1, X.sup.2 and X.sup.3 are the same or different and are hydrogen, halogen, lower alkyl having from one to four carbon atoms, lower alkoxy having from one to four carbon atoms, nitro, trifluoromethyl, hydroxy, or t-butyldimethylsilyloxy with the proviso that the case wherein X.sup.1, X.sup.2 and X.sup.3 are all hydrogen is not applicable have substantially strong and lasting vasodilative effects. Therefore, the compounds are useful as agents for treating disorders of the cardiovascular system, for example, antihypertensive agents, circulation improver and antianginal agents.

    Novel 1,4-dihydropyridine derivatives, process for preparing the same,
and agents for treating disorders of circulatory system
    5.
    发明授权
    Novel 1,4-dihydropyridine derivatives, process for preparing the same, and agents for treating disorders of circulatory system 失效
    新的1,4-二氢吡啶衍生物,其制备方法和用于治疗循环系统疾病的试剂

    公开(公告)号:US4824837A

    公开(公告)日:1989-04-25

    申请号:US881779

    申请日:1986-07-03

    摘要: 1,4-Dihydropyridine derivatives of the formula (1): ##STR1## wherein X is a halogen; R.sup.1 is a straight, branched or cyclic alkyl group having 1 to 10 carbon atoms, the group --(CH.sub.2).sub.n -Y [where n is an integer of 0 to 8, provided that n is an integer of 2 to 8 when Y is not bonded to COO-- through carbon; Y is a cyclic alkyl group having 3-6 carbon atoms, an aryl group having 6-10 carbon atoms, a pyrrolidinyl group, an imidazolidinyl group, a thienyl group, a furyl group, an imidazolyl group, a pyridyl group, a pyrimidinyl group, a morpholinyl group, a thiomorpholinyl group or a pyrrolizidinyl group, the group ##STR2## (where D is an aryl or aralkyl group having 6-15 carbon atoms which may be substituted by a halogenated alkyl group), or a 3-piperidinyl group substituted by a phenylalkyl group of 7-10 carbon atoms which may be substituted by one or two halogens], the group --(CH.sub.2).sub.m --O--Z (where m is an integer of 1 to 8; and Z is an alkyl or aryl group), or the group ##STR3## (where l is an integer of 1-7; A is a hydrogen atom, an alkyl group or an aryl group; and R.sup.3 and R.sup.4 which may be the same or different represent an alkyl, aryl or aralkyl group); and R.sup.2 is a lower alkyl group, and pharmaceutically acceptable acid addition salts thereof are effective for treating disorders of the circulatory system and are useful as hypotensives, cerebral circulation improvers and antianginal agents.Processes for producing the above copounds economically and effectively are also disclosed.

    摘要翻译: 式(1)的1,4-二氢吡啶衍生物:其中X是卤素; R1是具有1-10个碳原子的直链,支链或环状烷基,基团 - (CH 2)n Y [其中n是0至8的整数,条件是当Y不结合时n是2至8的整数 COO-通过碳; Y是具有3-6个碳原子的环状烷基,具有6-10个碳原子的芳基,吡咯烷基,咪唑烷基,噻吩基,呋喃基,咪唑基,吡啶基,嘧啶基 ,吗啉基,硫代吗啉基或吡咯烷基,基团(其中D是可被卤代烷基取代的具有6-15个碳原子的芳基或芳烷基)或3-哌啶基 由可被一个或两个卤素取代的7-10个碳原子的苯基烷基取代基团 - (CH 2)m OZ(其中m是1至8的整数; Z是烷基或芳基), 或基团(其中l为1-7的整数; A为氢原子,烷基或芳基; R 3和R 4可相同或不同,表示烷基,芳基或芳烷基 ); R2是低级烷基,其药学上可接受的酸加成盐对于治疗循环系统的病症是有效的,并且可用作低血糖剂,脑循环改善剂和抗血管药。 还公开了经济有效地生产上述组合物的方法。